论文部分内容阅读
目的研究探讨双黄连和利巴韦林注射液治疗小儿急性上呼吸道感染的临床效果。方法选取我院门诊收治的154例急性上呼吸道感染患儿,随机将其分为对照组和观察组,每组77例。观察组实施双黄连和利巴韦林注射液联合治疗,对照组仅实施利巴韦林注射液进行治疗。观察记录两组患儿的体温复原时长、临床治疗总有效率、咽痛复原时长、WBC计数复原时长、咳嗽消失时长等。结果治疗后观察组临床总有效率均显著高于对照组(P<0.05);治疗后观察组体温复原时长显著短于对照组(P<0.05);治疗后观察组咽痛复原时长、WBC计数复原时长、咳嗽消失时长短于对照组,但差异不具有显著性(P>0.05)。结论应用双黄连和利巴韦林注射液治疗小儿急性上呼吸道感染能有效抑制病情发展,减少病症带来的痛苦,有效缩短体温复原时长,改善由病毒引起的咳嗽、咽痛等不良反应,临床效果显著,值得应用于临床治疗。
Objective To study the clinical effect of Shuanghuanglian and Ribavirin injection on children with acute upper respiratory tract infection. Methods A total of 154 children with acute upper respiratory tract infection admitted to our hospital were randomly divided into control group and observation group with 77 cases in each group. Observation group implemented Shuanghuanglian and ribavirin combination therapy, the control group only the implementation of ribavirin injection treatment. The duration of temperature recovery, the total effective rate of clinical treatment, the recovery time of sore throat, the recovery time of WBC count, the disappearance of cough and so on were recorded and recorded. Results After treatment, the total effective rate in the observation group was significantly higher than that in the control group (P <0.05). After the treatment, the duration of body temperature recovery in the observation group was significantly shorter than that in the control group (P <0.05) Recovery time, cough disappeared longer than the control group, but the difference was not significant (P> 0.05). Conclusion Shuanghuanglian and ribavirin injection in children with acute upper respiratory tract infection can effectively inhibit the progression of the disease, reduce the pain caused by the illness, effectively shorten the duration of body temperature recovery, improve the virus caused by cough, sore throat and other adverse reactions, clinical The effect is significant, it is worth applying to clinical treatment.